Exact Sciences

Rick Baehner, MD checking in from #SABCS25 to discuss new data revealing the Oncodetect® test’s powerful prognostic performance in early triple-negative breast cancer. Learn more ⬇️ http://spr.ly/6041CEz37

Our work continues as we strive to broaden access to reliable cancer screening tools. The Cancerguard® multi-cancer early detection (MCED) test represents an important shift in how we detect cancer, and legislation like the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act will be key to expanding access for people covered by Medicare. Learn more about the growing momentum behind MCED testing. ⬇️

We're excited to join the global breast cancer community this week at #SABCS25. Our team is sharing data reinforcing our international leadership in breast cancer care: http://spr.ly/6041CBKs1

When you say ‘Wisconsin’, you’ve said it all! Congratulations to the University of Wisconsin-Madison for winning the Abbott and Big Ten blood donation competition. ❤️🦡

Let’s help save some lives!🩸This week, the Exact Sciences team and Badger #ExactSciencesAthletes donated blood and volunteered to help the University of Wisconsin-Madison secure the win in the Abbott and Big Ten's We Give Blood drive. Only two days left to participate. Give blood at any U.S. blood center through Dec. 5 and log your donation at http://spr.ly/60487NlLk.

A heartfelt thank-you to our amazing Exact Sciences teammates! We deeply appreciate the positivity, energy, and dedication you bring to work every day. Wishing you a joyful and Happy Thanksgiving!

We’re sharing data at #SABCS25 showcasing our commitment to advancing breast cancer care and providing actionable insights for patients and their health care providers: http://spr.ly/60417Wij3

We have some award-winning dogs! We’re pleased to share that our “Pick Up Your Poop” campaign, in collaboration with F Cancer, won an Anthem Award for its efforts to raise awareness and inspire action against colorectal cancer. See the PSA below and remember to listen to your furry friend and get screened. See more: http://spr.ly/60407WEKm The Anthem Awards

Today, we announced that Exact Sciences has agreed to be acquired by Abbott, one of the world’s most respected healthcare companies. The combination is expected to close in the second quarter of 2026, pending regulatory approval and Exact Sciences’ shareholder approval. For more than 16 years, we’ve worked to transform cancer diagnostics and improve patient lives. This next chapter will allow us to bring earlier answers to more people around the world. We’re proud of what our team has built — a purpose-driven company, innovative science, and life-changing tests that have already helped more than 25 million people. That mission will continue, stronger than ever, as part of Abbott. To our Exact Sciences team: thank you for your commitment, your compassion, and your belief in what we do every day. Read more: http://spr.ly/60447iu0p #HealthcareInnovation #CancerDiagnostics #MissionDriven

Colorectal cancer is on the rise in adults under the age of 50, which is why screening starting at the age of 45 is more important than ever. Tim was 46 when his doctor mentioned that the guideline-recommended age to screen had lowered from 50 to 45. He thought he had no reason to screen but agreed to complete a Cologuard® test. He was shocked when the result was positive, and a follow-up colonoscopy revealed stage III colon cancer. Tim’s colon cancer was more treatable because of when he took action. Had he waited until age 50, he might not be living cancer-free today. Keep watching via Katie Couric Media: http://spr.ly/60467ewXM